Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Aristo Bio-Tech and Lifescience IPO.
June 28, 2024 3:30:00 AM
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Published by : MorningstarJuly 1, 2024 11:19:00 AM
Artiva Biotherapeutics has become the latest biotech to set out IPO ambitions for the summer, as the allogeneic natural killer (NK) cell therapy company pushes its lead program through automimmune ...
Published by : FierceBiotechJuly 1, 2024 2:30:00 PM
Biopharma deal activity plummeted down to Earth in the second quarter, with just a handful of M&A transactions and IPOs studding the mostly dark skies. | The slow quarter follows an exciting first one ...
Published by : FierceBiotechJune 15, 2024 1:06:00 AM
The firm's principals include venture capitalists, investment bankers and a former high-ranking leader at Genentech. A cadre of venture capital and investment banking veterans are supporting an ...
Published by : The Business JournalsJune 12, 2024 7:17:00 PM
CrowdStrike marks the 5-year anniversay of its IPO with significant milestones and momentum and ... [+] being added to the S&P 500. As CrowdStrike marks the fifth anniversary of its IPO ...
Published by : ForbesJune 28, 2024 1:44:00 PM
The offering is expected to close on 1 July. Earlier this month, the US-based biotech said that it planned to use part of the IPO proceeds to advance its lead asset ESK-001 into multiple Phase III ...
Published by : Yahoo FinanceJuly 1, 2024 3:30:00 AM
Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet � today, it would be a vaccine for COVID-19. If these times have anything to say about it ...
Published by : Benzinga.comJune 28, 2024 5:35:00 AM
The twisty IPO may say more about investor appetite for biotech companies � even those with drugs in late-stage clinical trials � than it does about South San Francisco-based Alumis itself.
Published by : The Business JournalsJune 16, 2024 6:47:00 PM
Tempus is less a biotech company and more of a medical data one, but it could be the forerunner of a number of health-focused IPOs this year ... "Dozens" of other life sciences companies have ...
Published by : MSNJuly 1, 2024 3:30:00 AM
Unlike many unprofitable biotech companies, Regeneron was in the �green� and generated $4.3 billion in net income in 2022. Eylea could be vulnerable to biosimilars competition starting in 2024.
Published by : USA TodayJune 24, 2024 7:51:00 PM
Last week, Natasha and Alex jumped on Twitter Spaces to discuss the tale of two edtech IPOs: Duolingo, the consumer language learning company, and PowerSchool, the enterprise K-12 software platform.
Published by : TechCrunchThe allotment status of Aristo Bio-Tech and Lifescience Limited IPO is now available online. The public issue of Aristo Bio-Tech and Lifescience IPO was open on Jan 16, 2023 and closed for subscription on Jan 19, 2023. The equity shares of the company to be list at NSE SME
.
The IPO Shares of Aristo Bio-Tech and Lifescience Limited IPO are proposed to list on Monday, January 30, 2023 at NSE SME. The public issue of Aristo Bio-Tech and Lifescience IPO was opened on Jan 16, 2023 and closed for subscription on Jan 19, 2023. Aristo Bio-Tech and Lifescience IPO Listing Date and Information:
| Listing Date | Monday, January 30, 2023 |
| BSE Script Code | |
| NSE Symbol | ARISTO |
| Listing In | |
| ISIN | INE082101010 |
| Issue Price | ₹72 Per Equity Share |
| Face Value | ₹10 Per Equity Share |
SME : Aristo Bio-Tech and Lifescience Limited is entering in the capital market with an IPO of 1,812,800 Equity Shares of Rs 10 aggregating up to Rs 13.05 Crore. The price for the issue has been set at Rs 72 Per Equity Share.
Incorporated in 2005, Aristo Bio-Tech and Lifescience Limited is an agrochemical company. They are mainly engaged in the manufacturing, formulation, supplying, packaging, and job work services of various Pesticides.
The issue opens on Jan 16, 2023 and closes for subscription on Jan 19, 2023. The equity shares of the company to be list at NSE SME.
SME: The issue of Aristo Bio-Tech and Lifescience Limited opens on Jan 16, 2023 and closes for subscription on Jan 19, 2023. The equity shares of the company to be list at NSE SME. The price for the issue has been set at Rs 72 Per Equity Share.
The Aristo Bio-Tech and Lifescience IPO is proposed to open on January 16, 2023. The IPO application ends on January 19, 2023.
Retail investors can apply in the retail or non-institutional investor category from January 16, 2023 to January 19, 2023. The Aristo Bio-Tech and Lifescience IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Aristo Bio-Tech and Lifescience IPO will open for subscription on January 16, 2023. The public issue will close on January 19, 2023.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
